Search Orphan Drug Designations and Approvals
-
Generic Name: | iptacopan |
---|---|
Date Designated: | 05/18/2020 |
Orphan Designation: | Treatment of C3 glomerulopathy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-